CROSS-BORDER
INVESTMENT
Foreign-related arbitration under China’s new Arbitration Law
Revised Arbitration Law passed by the 17th Session of the 14th NPC Standing Committee
Shielding financial investors from M&A fraud liability
Financial investors face rising M&A fraud risks and need stronger legal safeguards
Compliance challenges under Indonesia’s new transfer pricing rules
Indonesia upgraded its transfer pricing rules under PMK No.172/2023, aligning with global efforts to curb profit shifting
Multinational antitrust reviews in pharma M&A
In recent years, M&A in the global biopharmaceutical sector has remained highly active
How can MNCs balance sanctions regimes?
China’s Anti-Foreign Sanctions Law creates new compliance risks for multinationals navigating conflicting global sanctions regimes
High time for A-share companies to list in Hong Kong
A-share companies are increasingly listing H shares on the SEHK
